Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Metropolis Healthcare Ltd. (METROPOLIS)
Market Closed
11 Aug, 10:00
XNSE
All
(2)
IN
(2)
XNSE
Primary
MSE
₹
566.
25
-6.4
-1.1176%
₹
90.98B
Market Cap
70.37
P/E Ratio
4%
Div Yield
201,903
Volume
0
Eps
₹
572.65
Previous Close
Watching
Watch
Add Transaction
Day Range
562.35
577
Year Range
412.25
609.05
Want to track
METROPOLIS
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Metropolis Healthcare Ltd. (METROPOLIS) Statistics
Valuation metrics
Market Cap
90.98B
Enterprise value
118.47B
Trailing P/E (ttm)
61.37
Forward P/E
35.19
PEG ratio
2.07
Price/Sales (ttm)
7.09
Price/Book (mrq)
7.7
Enterprise Value/Revenue
7.2
Enterprise Value/EBITDA
30.84
Overview
Shares outstanding
207.33M
Float
103.87M
Shares short
-
% Held by insiders
0.5%
% Held by institutions
0.44%
Average volume (10 days)
244.34K
Average volume (90 days)
319.73K
Price summary
52-Week low
412.25
52-Week high
609.05
Beta
-0.02
50-Day moving average
563.8
200-Day moving average
940.08
Dividends and splits
Forward annual dividend rate
4
Forward annual dividend yield
0.0093%
Trailing annual dividend rate
2
Trailing annual dividend yield
0.0036%
5-Year annual dividend yield
-
Payout ratio
0.12
Dividend Date
12 Jun 2026
Ex-Dividend Date
19 May 2026
Last split factor
4:1
Last split Date
20 Mar 2026
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.12%
Operating margin
0.25%
Operational effectiveness
Return on assets
0.09%
Return on equity
0.13%
Income Statement
Revenue (ttm)
15.66B
Revenue per share (ttm)
79.54
Quarterly revenue growth (yoy)
0.26%
Gross profit (ttm)
12.15B
EBITDA
3.45B
Net income to common (ttm)
1.68B
Diluted EPS (ttm)
9.18
Quarterly earnings growth (yoy)
0.32%
Balance Sheet
Total cash (mrq)
795.77M
Total cash per share (mrq)
9.81
Total debt (mrq)
2.01B
Total Debt/Equity (mrq)
0.15
Current ratio (mrq)
1.4%
Book value per share (mrq)
73.68
Cash Flow
Cash flow statement
1.9B
Levered free cash flow (LFCF)
1.45B